SMM-SNV Exome

About Mutagentech

Mutagentech, founded in 2018, is a private diagnostics company commercializing a proprietary sequencing platform called SMM-seq™. This technology uses rolling circle amplification to detect rare somatic mutations and structural variants with high accuracy, addressing a major challenge in studying genome instability in aging and disease. Led by a scientifically distinguished founding team, the company currently offers sequencing services directly to researchers and is in a pre-revenue or early-revenue stage, targeting the research tools and clinical diagnostics markets.

Therapeutic Areas